百濟(jì)神州收到FDA回復(fù)：疫情影響延緩PD-1上市申請(qǐng)審評(píng)時(shí)間，暫未收到對(duì)申報(bào)材料的異議

array(1) { [413166]=> array(2) { [2]=> array(3) { [0]=> string(12) "突發(fā)疫情" [1]=> string(18) "腫瘤免疫治療" [2]=> string(14) "百濟(jì)神州-U" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }